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INTRODUCTION:  Laparoscopic  sleeve  gastrectomy  (LSG)  is  an  accepted  technique  in  bariatric  surgery  for
reducing  obesity.  Recent  reports indicate  it to  be  effective  even  in children  but it has  not  been  tried  in
very  young  children.
PRESENTATION  OF  CASE:  We  report  here a case  of  a 2 and  half  years  old  child  subjected  to  LSG  for  his
morbid  obesity  and  associated  obstructive  sleep  apnea  and  bowing  of legs.  LSG  was  performed  after
investigations  ruled  out  hereditary  or genetic  causes  of obesity.  The  procedure  was  well  tolerated  without
any  complications  and  2 months  post  surgery,  the  obstructive  sleep  apnea  decreased  substantially.  The
child  was followed  up  for  two  years.  At  the  last  follow  up BMI  was  drastically  reduced  from  a  pre  surgical
value  of  41.1–24  kg/m2 at 24 months  post surgery.MI  reduction DISCUSSION: Prior to our report  the  youngest  child  to  undergo  sleeve  gastrectomy  was 5  years  old  from
Saudi  Arabia.  We  observed  LSG  to  be safe and  effective  in  reducing  obesity  and related  co morbidities  in
a  two  and  half  year’s  old  child.
CONCLUSION: The  results  suggest  that  LSG  can  be  a  safe and  effective  alternative  for  weight  control  in
morbidly  obese  children  even  of  less  than  3 years  of  age.  However  more  studies  and long  term  follow  up
is  essential  for monitoring  the  growth  and  development  of  children  subjected  to  LSG.
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. Introduction
Obesity among children is a worldwide problem.1 It is not only
ssociated with preventable long term health conditions such as
ypertension, type 2 diabetes mellitus (DM), dyslipidemia, obstruc-
ive sleep apnea (OSA), and orthopedic complications but also
esults in serious psychosocial complications.2,3 Recent studies
uggest that obesity and overweight even in children less than two
ears of age is associated with early morbidity.4 Overweight and
bese toddlers (<2 years of age), as compared to normal weight
hildren were observed to have more admissions as well as a larger
umber of repeated admissions, development delays and high inci-
ence rates of respiratory morbidity such as snoring, asthma and
tridor.4 Therefore reducing obesity in young children is essential
o reduce morbidity and also since obesity during childhood leads
o obesity in adulthood.5
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Severely obese children with co morbidities and those who  do
not respond to life style changes and pharmacotherapy get bene-
ﬁt from bariatric surgery.6 Laparoscopic Sleeve Gastrectomy (LSG)
is gaining acceptance for the treatment of morbid obesity under
several indications.7–10 As LSG proved to be effective in the short-
term in achieving considerable weight loss, it has been proposed
by some to be used solely as a bariatric procedure. Recent reports
show that morbid obesity and the associated co morbidities were
successfully managed by LSG even in children of 5 and 6 years of
age.5,6,11,12 However to our knowledge LSG has never been tried in
very young age children.
We  present here probably the ﬁrst case report of the successful
management of a two and a half year old morbidly obese boy with
sleep apnea and bowing of legs with laparoscopic sleeve gastrec-
tomy.
2. Case report
This  two-year-and-a-half old boy was referred from the pedi-
atric endocrinologist as a case of morbid obesity for surgical
Open access under CC BY license.assessment and management. His parents’ main complaint was an
abnormal increase in weight, snoring and apneoic attacks during
sleep requiring them to closely monitor his sleep. He was a prod-
uct of an uneventful delivery with a birth weight of 3 kg. He was
breast fed for 2 months and continued on formula milk up to one
year of age. Supplementary food was  introduced at 9 months (as
s Ltd. Open access under CC BY license. 
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omography of the brain.
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the upper GI tract showed normal opaciﬁcation of the remaining
stomach and no leak from anastomoses site (Fig. 4). The patientFig. 1. Computed t
ather mentioned). He was  well until 6 months of age, when the
arents noticed he was looking chubby and overweight, his weight
as 9.7 kg; they sought medical advice at 8 months of age. At pre-
entation to the endocrinologist he was 14 months of age with
 weight of 21.3 kg (BMI = 29 kg/m2). He was started on diet and
edical management and all his hormonal and chromosomal work
p was normal and there was no change in the milestones. The
atient had no family history of morbid obesity or genetic abnor-
ality. CT scan of the brain also showed no other causes of obesity
uch as pituitary or cerebellar tumor (Fig. 1). All attempts to con-
rol weight increase through diet and medical control failed and
ithin 4 months his weight increased by eight kilograms (29.3 kg,
MI  = 33 kg/m2). Although the parents were informed about the
mportance of a strict dietary regimen a full compliance cannot be
scertained mainly due to the different socio cultural habits and
he absence of the practice of calculating the caloriﬁc value of the
iet.
The increase in weight was associated with obstructive sleep
pnea symptoms and bowing of the legs. When he was presented
o the surgical clinic, he was 29.4 kg with a BMI  of 36 kg/m2 and he
as on 12.5 mcg  of l-thyroxin. The patient had another trial of med-
cal management and was referred to the obesity clinic for further
ietary management. However, his obstructive sleep symptoms
nstead of improving showed an increase in frequency and after 18
onths of therapy (weight = 33 kg, BMI  = 41 kg/m2) (Figs. 2 and 3),
e was admitted for a LSG which was performed in April 2010. Due
o an increase in the episodes of apnea and also due to the difﬁculty
n intubation preoperative endoscopy could not be performed.
A 32 F bougie was used and gastrectomy was started 3 cm prox-
mal to pylorus and carried up to 15 cm lateral to angle of his and
bout 1 cm away from the bougie to avoid tension on the suture
Fig. 2. Body weight pre and post LSG.Time duraon is  same as in Fig 3. 
Fig. 3. Body mass index pre and post LSG.
line. The gastric sleeve was closed using Eshelon staple (60 mm),
and was  reinforced with Seam guard. After the occlusion, insufﬂa-
tions of the stomach were performed using methylene blue and no
leak was detected. Post operative follow up also showed no leaks
or bleeding. Low-molecular-weight heparin (LMWH) was initiated
after surgery and discontinued after he started adequate mobiliza-
tion on day 3 post surgery. Post operative day 5 contrast study ofwas started orally on liquids ﬁve days post-operation and pro-
gressed to pureed diet. Post surgery, the child was put on anti reﬂux
Fig. 4. Post-operative day 5 upper GI contrast study.
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Table 1
Preoperative investigations.
Parameters Level/s
FBS 5.8 mmol/L
HBA1C 5.6 mmol/L
Cholesterol 4.01
Triglyceride 2.40 high
FT4 16.4 (12–22) pmol/L
TSH 7.080 H (0.27–4.2)
25  Hydroxy Vitamin D 33.3 L
Ferritin 15 L
Iron 5 L
T.I.B.C 59 N
Corrected calcium Normal
Inorganic phosphate Normal
Alkaline phosphatase Normal
Prolactin Normal
Cortisone Normal
GH Normal
Serum insulin Normal
C-peptide Normal
Calcium Normal
CBC Normal
resolving of knee pain were also observed in a 10 years old child
suffering with morbid obesity and Blount’s disease (tibia vara).10 A
more recent study also showed the successful reduction of morbid
Table 2
Post operative investigations.
2010
October
2011
March
2011
October
2012
March
FBS Normal
Ferritin 20 L Normal
U&E Normal
LFTs
Cholesterol
Triglyceride
FT4
TSH
Prolactin
Cortisone
GH
Iron Normal
25  Hydroxy Vitamin D
Calcium
T.I.B.CFig. 5. Pre and post operative BMI  Charts.
edication and was evaluated with an upper GI study after three
onths and the medication was stopped. However no complain of
eﬂux was observed during this period and also during the subse-
uent follow ups.
A reduction of 15% in body weight and 30% in BMI  was observed
t 2 months follow up post LSG and the obstructive sleep symp-
oms were considerably resolved. At the last follow up, 24 months
fter LSG, a considerable reduction in the body weight (27%; from
3 kg to 24 kg) and BMI  (41.46%; from 41 kg/m2 to 24 kg/m2), was
ecorded (Figs. 2 and 3). One of the limitations of this report is
hat the parents of the child did not comply with the provided
nstruction/s and more often showed a tendency to miss appoint-
ents and hence a regular time bound follow up was not possible
Fig. 5). Normalization in the pre surgical high levels of TSH and
riglycerides was observed at six months post LSG. Full blood count,
hyroid function test, liver function test, kidney function test, blood
lucose, cortisol, growth hormone and blood electrolytes were all
ithin normal limits at the last follow up at 24 months post LSG
Tables 1 and 2).
. Discussion
In recent years there has been renewed interest in the surgical
reatment of morbid obesity in concomitance with the epidemic of
besity and application of the laparoscopic techniques to the ﬁeld
f bariatric surgery as well.14 Among the different approaches of
ariatric surgery, LSG is being used both as a staged and stand alone
rocedure in adults.13 Bariatric surgery has also been suggested to
esult in sustained and clinically signiﬁcant weight loss in pedi-
tric patients with morbid obesity but with a potential for serious
omplications.14 However the importance of bariatric surgery for
educing obesity in children is being increasingly realized.6,11,15,16We  observed LSG to be safe and effective in reducing obesity and
elated co morbidities in the two years and 6 months old child. The
rocedure was well tolerated and the child was  followed up for 24
onths without any complications and normal milestones. Prior toU&E Normal
LFTs Normal
our report the youngest child to undergo sleeve gastrectomy was a
5 years old from Saudi Arabia.6
Data from other recent studies also show a positive outcome
in children undergoing LSG surgery for morbid obesity and the
associated co morbidities. Till et al.12 performed LSG in a pediatric
series of 4 patients with a mean age of 14.5 years and at 12 months
follow up no complications including malnutrition or vitamin deﬁ-
ciency were observed. Furthermore a signiﬁcant improvement in
the associated co morbidities such as Type 2 diabetes, hyperten-
sion etc. was  observed. An earlier study has also shown a reduction
in body weight and related co morbidities in a 6 years old child
following LSG.17 A very recent review of LSG performed on 108
obese children and young adults by a single surgeon in Saudi Ara-
bia also showed LSG to be fairly effective in short term weight loss
in more than 90% of pediatric patients and resolution of 70% of
co-morbid problems associated with obesity.6 Beneﬁcial effects of
LSG in the form of reduction of BMI  from 42 kg/m2 to 28 kg/m2 andCorrected calcium
Inorganic phosphate
Alkaline phosphatase
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besity and associated obstructive sleep apnea, acanthosis nigri-
ans and hypertension by LSG in a young patient.8
Besides weight loss and metabolic beneﬁts, bariatric proce-
ures including LSG has wider implications and are associated with
mproving the quality of life by reversing/reducing several obe-
ity related co morbidities such as obstructive sleep apnea.18 We
bserved that the problem of obstructive sleep apnea was consid-
rably reduced within 2 months of the procedure. Earlier studies
oth in adults and children have also shown a reduction in the
revalence of obstructive sleep apnea in obese patients following
ariatric surgeries.6–8,19,20
Serum proteomic and metobonomic proﬁling after LSG in chil-
ren and adolescents has revealed that it leads to changes in amino
cids and in lipid metabolism and decrease in obesity related
iomarkers.21 These biomarkers will help in providing measures
or monitoring therapy and the induced physiological changes fol-
owing LSG.21
The reduction in the BMI  and the associated co morbidities in the
hild post gastrectomy, lack of complications at two  years follow
p and normal milestones suggest that gastrectomy is safe and
an be performed in young children to reduce BMI  and the asso-
iated co morbidities. However a potential disadvantage of LSG
s its irreversibility and the lack of proper understanding of the
onsequences by the young children. Therefore a very honest and
pen discussion with the parents regarding the permanence and
rreversible nature of the procedure is essential during the decision
aking process.
. Conclusion
LSG may  be used in very young children provided they have co-
orbidities and no improvement with medical and conservative
ultidisciplinary management. In our patient, the weight reduc-
ion was signiﬁcant and his associated symptoms resolved with
ime indicating its safety and efﬁcacy.
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